Clinical and Experimental Gastroenterology
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Selected luminal mucosal complications of adult celiac disease
(10025) Total Article Views
Authors: Hugh J Freeman
Published Date February 2009
Volume 2009:2 Pages 9 - 12
Hugh J Freeman
Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada
Abstract: Celiac disease is a gluten-dependent intestinal disorder that appears to be associated with several clinical conditions. Some involve the luminal mucosa of the stomach and intestinal tract and may, occasionally, complicate the course of celiac disease. Collagenous colitis has been associated with celiac disease and may lead to chronic diarrhea. Conversely, some of these clinical disorders that involve the luminal mucosa of the stomach and intestine may represent the initial clinical presentation of celiac disease. These disorders should be considered in patients with celiac disease who develop recurrent or refractory symptoms despite adherence to a strict gluten-free diet. Detection of collagenous disorders that affect the luminal mucosa of the stomach or intestinal tract may result in recognition of underlying celiac disease.
Keywords: celiac disease, collagenous gastritis, collagenous sprue, collagenous colitis, gluten-free diet
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Other articles by Professor Hugh Freeman
Readers of this article also read:
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility study
- Amino acid-responsive Crohn's disease: a case study
- Oropharyngeal Crohn’s disease
- Methylnaltrexone in the treatment of opioid-induced constipation